Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.72 EUR | -0.09% | -0.35% | +2.43% |
04-25 | Transcript : Azelis Group NV, Q1 2024 Sales/ Trading Statement Call, Apr 25, 2024 | |
04-18 | EQT Weighs Options for Belgian Chemical Distributor Azelis | MT |
Sales 2024 * | 4.42B 4.72B 6.46B | Sales 2025 * | 4.62B 4.94B 6.75B | Capitalization | 5.54B 5.92B 8.1B |
---|---|---|---|---|---|
Net income 2024 * | 253M 271M 370M | Net income 2025 * | 277M 296M 405M | EV / Sales 2024 * | 1.5 x |
Net Debt 2024 * | 1.1B 1.18B 1.61B | Net Debt 2025 * | 936M 1B 1.37B | EV / Sales 2025 * | 1.4 x |
P/E ratio 2024 * |
21.4
x | P/E ratio 2025 * |
20.6
x | Employees | 3,481 |
Yield 2024 * |
1.26% | Yield 2025 * |
1.46% | Free-Float | 52.08% |
Latest transcript on Azelis Group NV
1 day | -0.09% | ||
1 week | -0.35% | ||
Current month | +15.98% | ||
1 month | +15.51% | ||
3 months | +19.14% | ||
6 months | +41.21% | ||
Current year | +2.43% |
Managers | Title | Age | Since |
---|---|---|---|
Anna Bertona
CEO | Chief Executive Officer | 57 | 15-12-31 |
Thijs Bakker
DFI | Director of Finance/CFO | 50 | 15-12-31 |
Evy Hellinckx
PRN | Corporate Officer/Principal | - | 12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 54 | 17-12-31 | |
Director/Board Member | 48 | 17-12-31 | |
Antonio Trius
CHM | Chairman | 69 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 22.72 | -0.09% | 232,091 |
24-04-25 | 22.74 | -1.13% | 157,513 |
24-04-24 | 23 | -1.37% | 134,722 |
24-04-23 | 23.32 | +0.60% | 202,928 |
24-04-22 | 23.18 | +1.67% | 159,265 |
Real-time Euronext Bruxelles, April 26, 2024 at 11:35 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.43% | 5.92B | |
+56.60% | 91.85B | |
+19.61% | 63.05B | |
+8.10% | 42.1B | |
+27.08% | 30.34B | |
+21.43% | 28.92B | |
+16.39% | 21.62B | |
+16.68% | 17.92B | |
-3.76% | 12.84B | |
-27.24% | 5.61B |
- Stock Market
- Equities
- AZE Stock